TCT 15: Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent in Patients Undergoing Primary Percutaneous Coronary Intervention: 3-Year Follow-up From the COMPARE II Trial

Presenter: Georgios Vlachojannis, MD

REGISTER for free or LOG IN to view this content

TCT 15: Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent in Patients Undergoing Primary Percutaneous Coronary Intervention: 3-Year Follow-up From the COMPARE II Trial

We Recommend